REZIVERTINIB
UNII U65F5M6BD5

Substance Identification & Data

This profile provides standardized clinical and technical data for Rezivertinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U65F5M6BD5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1835667-12-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U65F5M6BD5

CAS Registry Number

1835667-12-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REZIVERTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H30N6O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

BPMZUKYFIDPLEA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C154286

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

118912975

Unique identification number in the NCBI database of chemical substances.

INN ID

11229

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cn1c2c(c(c1)-c3nc(ncc3)Nc4c(OC)cc(c(c4)NC(C=C)=O)OCCN(C)C)cccc2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rezivertinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.